Funds holding APIMEDS PHARMACEUTICALS US INC
4 funds declare a position · 0 ETFs and 4 other funds · 217.2K $ · US03771D1028
Each line carries its report date.
| Rank | Fund | Shares | Value | Weight | |
|---|---|---|---|---|---|
| 1 | VANGUARD INSTITUTIONAL TOTAL STOCK MARKET INDEX FUND VANGUARD INSTITUTIONAL INDEX FUNDS | 60,976 | 109.1K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 2 | VANGUARD EXTENDED MARKET INDEX FUND VANGUARD INDEX FUNDS | 34,953 | 62.5K $ | 0.00 % | as of Mar 31, 2026 · Original filing |
| 3 | Fidelity Extended Market Index Fund Fidelity Concord Street Trust | 23,750 | 32.3K $ | 0.00 % | as of Feb 28, 2026 · Original filing |
| 4 | Fidelity Series Total Market Index Fund Fidelity Concord Street Trust | 9,729 | 13.2K $ | as of Feb 28, 2026 · Original filing |
Institutional managers
4 managers declare this company to the SEC (Form 13F). These positions are not counted in the totals above: a manager and its own funds file separately.
| Manager | Shares | Value | |
|---|---|---|---|
| Hemenway Trust Co LLC | 274,000 | 490.3K $ | as of Mar 31, 2026 |
| GEODE CAPITAL MANAGEMENT, LLC | 40,051 | 71.7K $ | as of Mar 31, 2026 |
| TWO SIGMA SECURITIES, LLC | 10,550 | 18.9K $ | as of Mar 31, 2026 |
| UBS Group AG | 4,187 | 7.5K $ | as of Mar 31, 2026 |